User profiles for Serdar Farhan
Serdar FarhanZena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, NY, NY Verified email at mountsinai.org Cited by 2771 |
Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents
…, AS Kini, SK Sharma, M Faggioni, S Farhan… - Journal of the American …, 2017 - jacc.org
Background : Recent evidence suggests that bioresorbable vascular scaffolds (BVS) are
associated with an excess of thrombotic complications compared with metallic everolimus-…
associated with an excess of thrombotic complications compared with metallic everolimus-…
Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation: JACC State-of-the-Art Review
S Farhan, JJ Silbiger, JL Halperin, L Zhang… - Journal of the American …, 2022 - jacc.org
The conventional view holds that functional mitral regurgitation (MR) is caused by restriction
of leaflet motion resulting from displacement of the papillary muscle-bearing segments of …
of leaflet motion resulting from displacement of the papillary muscle-bearing segments of …
Prothrombotic milieu, thrombotic events and prophylactic anticoagulation in hospitalized COVID-19 positive patients: a review
MJ Cryer, S Farhan, CC Kaufmann… - Clinical and Applied …, 2022 - journals.sagepub.com
The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in significant morbidity
and mortality worldwide. Although initial reports concentrated on severe respiratory illness, …
and mortality worldwide. Although initial reports concentrated on severe respiratory illness, …
Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes
Women with previous gestational diabetes (pGDM) are frequently insulin-resistant, which
could relate to intramyocellular lipid content (IMCL). IMCL were measured with 1 H nuclear …
could relate to intramyocellular lipid content (IMCL). IMCL were measured with 1 H nuclear …
[HTML][HTML] Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome
…, I Tentzeris, R Jarai, KM Katsaros, S Farhan… - PloS one, 2014 - journals.plos.org
Objectives ST2 is a receptor for interleukin (IL)-33. We investigated an association of soluble
ST2 (sST2) and IL-33 serum levels with different clinical stages of coronary artery disease. …
ST2 (sST2) and IL-33 serum levels with different clinical stages of coronary artery disease. …
Coronary calcification and long-term outcomes according to drug-eluting stent generation
Objectives The aim of this study was to evaluate the long-term impact of coronary artery
calcification (CAC) on outcomes after percutaneous coronary intervention and the respective …
calcification (CAC) on outcomes after percutaneous coronary intervention and the respective …
Complementary role of copeptin and high‐sensitivity troponin in predicting outcome in patients with stable chronic heart failure
I Tentzeris, R Jarai, S Farhan… - European journal of …, 2011 - Wiley Online Library
Aims Copeptin, the C‐terminal part of the vasopressin pro‐hormone, is elevated after myocardial
infarction and predicts adverse outcome. In the present study we investigated whether …
infarction and predicts adverse outcome. In the present study we investigated whether …
Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention
Background : Data on the impact of residual inflammatory risk (RIR) in patients undergoing
percutaneous coronary intervention (PCI) with baseline low-density lipoprotein cholesterol (…
percutaneous coronary intervention (PCI) with baseline low-density lipoprotein cholesterol (…
Ticagrelor with or without aspirin after PCI: the TWILIGHT platelet substudy
Background An evolving strategy in the setting of percutaneous coronary intervention (PCI)
involves withdrawal of acetylsalicylic acid (ASA), or aspirin, while maintaining P2Y 12 …
involves withdrawal of acetylsalicylic acid (ASA), or aspirin, while maintaining P2Y 12 …
Sex differences among patients with high risk receiving ticagrelor with or without aspirin after percutaneous coronary intervention: a subgroup analysis of the …
Importance Shortened dual antiplatelet therapy followed by potent P2Y12 receptor inhibitor
monotherapy reduces bleeding without increasing ischemic events after percutaneous …
monotherapy reduces bleeding without increasing ischemic events after percutaneous …